Xiangdong Gao

Title: Innovations of Xiangdong Gao

Introduction

Xiangdong Gao is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative peptides and recombinant proteins. With a total of two patents to his name, Gao's work focuses on enhancing immunogenicity and improving drug efficacy.

Latest Patents

Gao's latest patents include the "Helper epitope peptide and application thereof." This invention involves a helper epitope peptide obtained by replacing one or two amino acid residues in the helper T cell epitope PADRE with 4-nitrophenylalanine. The peptide is effective in enhancing the immunogenicity of antigens or antigenic epitopes, making it valuable for vaccine development.

Another significant patent is the "Modified recombinant human endostatin and uses thereof." This invention describes a modified recombinant human endostatin with a specific structure that enhances stability in vivo, improves blood drug concentration, and prolongs half-life. This innovation markedly increases the activity of inhibiting endothelial cell proliferation, thereby reducing drug dosage and administration frequency. It also has applications in preparing anti-tumor pharmaceutical compositions.

Career Highlights

Xiangdong Gao has worked with prominent institutions such as China Pharmaceutical University and Jiangsu Simcere Pharmaceutical R&D Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Gao has collaborated with notable colleagues, including Wenbing Yao and Hong Tian. These partnerships have likely facilitated the advancement of his research and innovations.

Conclusion

Xiangdong Gao's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to enhancing medical treatments. His work continues to impact the development of effective therapies and vaccines.